SUMMARY Induction of hypertension by implantation or injection of deoxycorticosterone acetate (DOCA) requires a dose well above the physiological range. The objective of this study was to produce hypertension in rats by chronic infusion of d-aldosterone, a more potent mineralocorticoid. Aldosterone infused at a dose of 1 Mg/hr for 4 weeks gave a maximal rise in systolic blood pressure (132 ± 3 vs 203 ± 7 mm Hg). A significant rise in blood pressure was achieved at 0.1 ng/ht (170 ± 6 mm Hg) which was associated with a 2.3-fold rise in plasma aldosterone levels (7.6 ± 0.4 vs 17.7 ± 2.2 ng/dl). A series of isotope flux studies on the aorta and femoral artery from hypertensive animals demonstrated increases in "K and M C1 turnover. In both vessels the largest changes in ion turnover were observed in vessels from animals infused with aldosterone at 0.25 fig/hr. Increases in "K and 9< G turnover were detected as early as 1 week after the start of aldosterone infusion, well before a significant rise in blood pressure had occurred. (Hypertension 4: 374-381, 1982) KEY WORDS • aldosterone • vascular smooth muscle • ion transport • radioisotopes S INCE its discovery by Conn and Louis 1 in 1955, primary aldosteronism has been considered a causative factor in at least some hypertensive patients. Experimentally, mineralocorticoid excess combined with high salt intake and reduced renal mass has been shown to cause hypertension in at least some species of animals, mainly, in the rat and young pig. DOCA salt treatment, particularly in the rat, has therefore become a well-established model of mineralocorticoid hypertension. In the majority of clinical cases, however, mineralocorticoid-related hypertension is due to an excess of aldosterone and not DOCA.2 Hypersecretion of DOCA is rarely observed clinically except in unusual cases of congenital adrenal-cortical enzymatic deficiencies. Moreover, induction of mineralocorticoid hypertension in experimental animals requires administration of DOCA in pharmacological doses. For example, Grekin et al. 8 reported that during 40 days of DOCA administration to young pigs, plasma DOCA levels remain elevated at least 10 fold over preimplantation levels, well above physiological levels.